Barclays’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.81M | Sell |
191,731
-42,729
| -18% | -$1.52M | ﹤0.01% | 1390 |
|
2025
Q1 | $7.96M | Buy |
234,460
+107,889
| +85% | +$3.66M | ﹤0.01% | 1147 |
|
2024
Q4 | $4.12M | Sell |
126,571
-33,779
| -21% | -$1.1M | ﹤0.01% | 1740 |
|
2024
Q3 | $7.81M | Sell |
160,350
-35,663
| -18% | -$1.74M | ﹤0.01% | 1186 |
|
2024
Q2 | $8.68M | Sell |
196,013
-10,494
| -5% | -$465K | ﹤0.01% | 952 |
|
2024
Q1 | $11.6M | Buy |
206,507
+19,122
| +10% | +$1.07M | ﹤0.01% | 947 |
|
2023
Q4 | $11.3M | Sell |
187,385
-93,709
| -33% | -$5.64M | ﹤0.01% | 995 |
|
2023
Q3 | $18.9M | Buy |
281,094
+197,357
| +236% | +$13.3M | 0.01% | 688 |
|
2023
Q2 | $5.78M | Sell |
83,737
-139,801
| -63% | -$9.65M | ﹤0.01% | 1151 |
|
2023
Q1 | $10.8M | Sell |
223,538
-248,716
| -53% | -$12M | ﹤0.01% | 782 |
|
2022
Q4 | $23.6M | Buy |
472,254
+171,042
| +57% | +$8.54M | 0.01% | 593 |
|
2022
Q3 | $12.3M | Buy |
301,212
+8,300
| +3% | +$339K | 0.01% | 757 |
|
2022
Q2 | $16.1M | Buy |
292,912
+47,586
| +19% | +$2.62M | 0.01% | 660 |
|
2022
Q1 | $8.92M | Buy |
+245,326
| New | +$8.92M | 0.01% | 905 |
|